Ipsen SA (IPN)

Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA and an Investment Account
Sell

€103.20

Buy

€103.80

arrow-up€1.40 (+1.37%)

Prices updated at 30 May 2025, 16:35 CEST
| Prices minimum 15 mins delay
|
Prices in EUR
Ipsen SA is a pharmaceutical company. The company mainly develops and manufactures products to serve the oncology, endocrinology, neurosciences, and primary care areas mainly across the European markets.
FTSE EuroFirst 300
arrow-up0.17%
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Chairman
Mr. Antoine Flochel
CEO
Mr. David Loew
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
5,358
Head office
70 rue Balard
Paris
France
75015
mobile
+33 158335000
letter
investor.relations@ipsen.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Dr. Margaret A. Liu, M.D.
Independent Director
-
Ms. Karen Witts
Independent Director
-
Ms. Carol Xueref
Director
-
Dr. Piet Wigerinck, PhD
Independent Director
-
Mr. David Loew
Director and Chief Executive Officer
-
Dr. Pascal Touchon, D.V.M.
Independent Director
-
Mr. Marc de Garidel
Chairman of the Board
-
Mr. Antoine Flochel
Vice Chairman of the Board
-
Ms. Anne Beaufour
Director
-
Mr. Henri Beaufour
Director
-
Mr. Philippe Bonhomme
Director
-
Ms. Laetitia Ducroquet
Director
-
Ms. Michele Ollier
Director
-
Ms. Naomi Binoche
Director
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
Vanguard Group Inc996,889
Grantham, Mayo, Van Otterloo & Co., LLC955,256
GMO Intl Op Value Composite906,476
BlackRock Fund Advisors769,834
ODDO BHF Asset Management SAS621,238

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
No data
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.